The person diagnosed with prostate cancer most likely already knows his prostate-specific antigen (PSA) level and his Gleason score.
These tests tell the doctor how far the cancer has progressed but not necessarily the “aggressiveness” of the disease.
Since cancer is the uncontrolled rapid growth of abnormal cells, an aggressive prostate tumor carries the potential risk of growing and spreading rapidly to other parts of the body.
Bruce lives with prostate cancer. He explains how Prolaris has given him the confidence to enjoy love and life without having to worry about if he and his doctor have made the best decision for his treatment.
“I have to say that I am a blessed person. The one thing I can say about my relationship with Myriad and taking the Prolaris test is it has given me peace of mind to ‘live in the now.’ The fact that I have Prostate cancer, makes me realize my time on this planet is FINITE!!! I have learned to enjoy every moment and seize the day. Life is precious – Myriad and their scientific advancements have given me time to enjoy it.”
Want to save $1.32 billion in healthcare spend annually?
That’s how much industry experts estimate is wasted each year on overtreating prostate cancer patients who will never die of that cancer. How is this possible? Don’t existing protocols guide urologists on the optimal treatment path for their patients? Wouldn’t urologists only treat what needs to be treated? It seems like it would be that simple, but it isn’t. Both the American Urology Association (AUA) and the National Comprehensive Cancer Network (NCCN) leave all or most treatment options open for low-, intermediate-, and high-risk prostate cancers.
“Wait a Minute, This is Not Happening To Me”
An elevated PSA level prompted Howard to see a urologist and undergo further testing for prostate cancer. After being diagnosed, Howard and his physician looked at their treatment options and decided on surgery. Learn how Prolaris testing has helped give him peace of mind going forward.
About 1 in 7
American men will have prostate cancer during his lifetime.1
Prostate Cancer is the 2nd
cancer among men.1
Although prostate cancer is a serious disease, it is important to note that
many men do not die from prostate cancer alone.
men in the United States who have been diagnosed with prostate cancer at some point are still alive today.1
CHEMOTHERAPY & NEW THERAPIES
These treatments may also be used alone or in combination with one another. The doctor should be able to describe the treatment choices, the expected results, and the possible side effects of each treatment. The patient and the doctor should work together to develop a treatment plan. Before treatment starts, ask your doctor about possible side effects and how treatment may change your normal activities.
Any man who has been diagnosed with prostate cancer is appropriate for Prolaris testing.
Prolaris testing will allow you and your doctor to learn more about the aggressiveness of your prostate cancer tumor. Based on the results of the Prolaris test, you and your doctor will be able to make a more informed decision on your course of treatment. Many men who have less aggressive prostate tumor growth can be successfully treated via active surveillance and not have to undergo surgery. Prolaris will help to guide you towards the most optimal treatment plan that’s tailored specifically to you.